TAO Synergies (TAOX) Assets (2019 - 2026)
TAO Synergies' (TAOX) quarterly Assets came in at $21.1 million in Q2 2026, up 6.63% on a YoY basis from $19.8 million in Q2 2025, and down 32.03% quarter-over-quarter from $31.0 million in Q1 2026.
Analysis
TAO Synergies (TAOX) Assets (2019 - 2026) Analysis & Trends
TAO Synergies (TAOX) has reported Assets for 8 consecutive years, with $21.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets rose 6.63% year-over-year to $21.1 million; the trailing twelve-month figure through Jun 2026 stood at $21.1 million (up 6.63% YoY), and the FY2025 full-year result was $25.8 million, up 45.68% from the prior year.
- Assets fell to $21.1 million in Q2 2026 per TAOX's latest filing, from $31.0 million in the prior quarter.
- Across five years, Assets topped out at $38.6 million in Q4 2022 and bottomed at $15.3 million in Q1 2025.
- Historically, Assets has averaged $27.3 million across 5 years, with a median of $28.9 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Assets sank 47.86% in 2025, then surged 102.54% in 2026.
- Over 5 years, Assets stood at $38.6 million in 2022, then dropped by 19.41% to $31.1 million in 2023, then sank by 43.0% to $17.7 million in 2024, then soared by 45.68% to $25.8 million in 2025, then fell by 18.31% to $21.1 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $21.1 million, $31.0 million, and $25.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn | 10.03 Bn |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn | 10.96 Bn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn | 5.31 Bn |
| 10 | TAO Synergies | 30.79 Mn | 30.79 Mn | - | 21.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.10 Mn |
| Mar 31, 2026 | 31.05 Mn |
| Dec 31, 2025 | 25.84 Mn |
| Sep 30, 2025 | 18.36 Mn |
| Jun 30, 2025 | 19.79 Mn |
| Mar 31, 2025 | 15.33 Mn |
| Dec 31, 2024 | 17.73 Mn |
| Sep 30, 2024 | 22.83 Mn |
| Jun 30, 2024 | 28.39 Mn |
| Mar 31, 2024 | 29.40 Mn |
| Dec 31, 2023 | 31.11 Mn |
| Sep 30, 2023 | 32.36 Mn |
| Jun 30, 2023 | 33.44 Mn |
| Mar 31, 2023 | 36.53 Mn |
| Dec 31, 2022 | 38.61 Mn |
| Sep 30, 2022 | 27.35 Mn |
| Jun 30, 2022 | 29.58 Mn |
| Mar 31, 2022 | 32.35 Mn |
| Dec 31, 2021 | 35.52 Mn |
| Sep 30, 2021 | 32.36 Mn |